World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03260231
Date of registration: 11/08/2017
Prospective Registration: No
Primary sponsor: University of Belgrade
Public title: Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma Lymphoseed
Scientific title: Effects of Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma
Date of first enrolment: May 12, 2017
Target sample size: 40
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03260231
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Care Provider, Investigator).  
Phase:  N/A
Countries of recruitment
Serbia
Contacts
Name:     Zorica Cvetkovic, MD PhD
Address: 
Telephone: +381641302624
Email: zokabora@yahoo.com
Affiliation: 
Name:     Vesna Vucic, PhD
Address: 
Telephone: +381113031997
Email: vesna.vucic.imr@gmail.com
Affiliation: 
Name:     Vesna Vucic, PhD
Address: 
Telephone:
Email:
Affiliation:  Institute for medical research
Key inclusion & exclusion criteria

Inclusion Criteria:

- Histologically confirmed Non-Hodgkin lymphoma

- Patients able to understand requirements of the study and provide written informed
consent

Exclusion Criteria:

- Previous radio- or chemotherapy

- Other serious chronic diseases

- Statin therapy

- Presence of allergy on any seeds

- Use of fat-based dietary supplements (such as fish oil, evening primrose oil etc) 3
months prior to study



Age minimum: 20 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Non-hodgkin Lymphoma
Intervention(s)
Dietary Supplement: Milled seed mix
Primary Outcome(s)
Change in disease status [Time Frame: Baseline, 5 months, 1 year]
Change in quality of life questionnaire scores [Time Frame: Baseline, 5 months, 1 year]
Secondary Outcome(s)
Changes in lipid profiles [Time Frame: Baseline, 5 months, 1 year]
Changes in parameters of oxidative stress [Time Frame: Baseline, 5 months]
Changes in body weight [Time Frame: Baseline, 5 months, 1 year]
Changes in CRP [Time Frame: Baseline, 5 months, 1 year]
Changes in leukocyte count [Time Frame: Baseline, 5 months, 1 year]
Changes in interleukin (IL)-6 [Time Frame: Baseline, 5 months, 1 year]
Changes in plasma fatty acids [Time Frame: Baseline, 5 months, 1 year]
Secondary ID(s)
145/1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history